VIDAL
Parapharmacy
Updated on 04/09/2026
Multidose bottle of 10 mL (EAN 3614790000712).
* Gentle preservative which, on contact with the ocular surface, transforms into components naturally present in tears.
Elixya is designed to remain on the ocular surface, providing lasting relief of the symptoms of dry eye by supplementing the natural tear film with essential components. Elixya is hypotonic and relieves symptoms by helping to restore the physiological osmotic balance of the tear film and ocular surface.
Elixya is compatible with all types of soft and rigid contact lenses. The solution can be instilled while lenses are worn for a marked improvement in lens comfort, all day long.
The product does not stain clothing or contact lenses.
Elixya may be used every day and as often as desired.
There is no limit on the duration of use.
May be used for 2 months after first opening.
Discard this medical device 2 months after opening.
CHAUVIN Laboratory
416, rue Samuel-Morse. CS 99535. 34961 Montpellier
Tel : 04 67 12 30 30
Parapharmacy
Updated on 04/09/2026
CE ELIXYA®
Forms and presentations
Sterile solution (clear, pink in colour) for ophthalmic use:Multidose bottle of 10 mL (EAN 3614790000712).
Composition
Hyaluronic acid (in the form of sodium hyaluronate): 0,15 %; polyethylene glycol 8000 (PEG 8000): 0,5 %; essential electrolytes (potassium chloride, calcium chloride, magnesium chloride, sodium chloride); vitamin B12; preservative: Oxyd®*.* Gentle preservative which, on contact with the ocular surface, transforms into components naturally present in tears.
Properties
Elixya, ophthalmic solution, is a medical device that contains essential components naturally present on the surface of the eye and in tears, including sodium hyaluronate, with moisturising properties, nutrients and electrolytes (such as potassium, magnesium, sodium and calcium). PEG 8000 is an additional humectant that prolongs the duration of hydration. Vitamin B12 gives Elixya its pink colour, which disappears quickly when the eyes blink.Elixya is designed to remain on the ocular surface, providing lasting relief of the symptoms of dry eye by supplementing the natural tear film with essential components. Elixya is hypotonic and relieves symptoms by helping to restore the physiological osmotic balance of the tear film and ocular surface.
Elixya is compatible with all types of soft and rigid contact lenses. The solution can be instilled while lenses are worn for a marked improvement in lens comfort, all day long.
The product does not stain clothing or contact lenses.
Indications
Moderate to severe sensations of dry eye.Directions for use
Instil one drop of Elixya into the eye 3 to 5 times per day, or more frequently if necessary.Elixya may be used every day and as often as desired.
There is no limit on the duration of use.
Contraindications
Do not use this product in case of hypersensitivity to any of the components.Precautions for use
Local hypersensitivity reactions have been very rarely reported. In such cases, treatment must be discontinued.
Avoid any contact between the tip of the bottle and the surface of the eye, in order to avoid the risk of injury or contamination of the solution.
Do not use Elixya after the expiry date.
Do not use this product if the bottle is damaged.
- Risk of interaction:
- Wait approximately 15 minutes before using another eye product.
STORAGE CONDITIONS
Store at a temperature between +2 °C and + 25 °C and protected from light.May be used for 2 months after first opening.
Discard this medical device 2 months after opening.
ADMINISTRATIVE INFORMATION
| Medical device, class IIb. CE marking 0483. | |
LPPR rate:
6,59 euros (bottle of 10 ml, unit box; LPPR code 1132181).
Manufacturer: Dr. Gerhard Mann chem.-pharm. Fabrik GmbH, Brunsbütteler Damm 165/173, 13581 Berlin, Germany.| Maximum retail selling price: | 9,27 euros. |
| Covered indication: | |
| Symptomatic treatment of dry eye with keratitis or dry keratoconjunctivitis in 3e intention after failure of low-viscosity tear substitutes and gels (carbomer type). | |
| The use of Elixya is not indicated in patients wearing contact lenses. | |
| Prescribing and use conditions: | |
| - Prescription by an ophthalmologist after diagnosis of keratitis or dry keratoconjunctivitis, notably by a colorimetric test performed with a slit lamp; | |
| - Initial prescription not to exceed 6 months of treatment. At the end of this period, reassessment ideally by an ophthalmologist for a possible renewal of the prescription. | |
CHAUVIN Laboratory
416, rue Samuel-Morse. CS 99535. 34961 Montpellier
Tel : 04 67 12 30 30
Source: VIDAL · Updated on 10/11/2026. This information does not replace advice from a healthcare professional.